Conjunctival Leaking Bleb after Cross-Linking using Ribofl avin and UVA: A Histopathological Study
Journal Title: Journal of Clinical Research and Ophthalmology - Year 2017, Vol 4, Issue 1
Abstract
Two conjunctival leaking blebs were excisioned to assess by histological methods the cellular effect after corneal cross-linking treatment. Sections were stained with hematoxylin-eosin and immunohistochemistry with the Ki67 antibody. The proliferating marker Ki67 was detected only in both treated pieces with a very significant increase in epithelial proliferating cells in one case but not in the other. Further studies are necessary to continue understanding the response to treatment of the ischemic blebs with CXL and riboflavin.
Authors and Affiliations
Loscos-Arenas Jordi, Tapia Gustavo, Moll-Udina Aina, Romanic Nevena, Romera Pau
Keywords
Related Articles
- EP ID EP231202
- DOI 10.17352/2455-1414.000039
- Views 84
- Downloads 0
Epidemiolgy of Rhegmatogenous Retinal Detachment in Dubrovnik-Neretva County
Aim: This study is the first examination of the incidence of rhegmatogenous retinal detachment (RRD) in Dubrovnik- Neretva County, Croatia. Method: Study is a retrospective and analyzed documentation from the Retinal cli...
Congenital Unilateral Lamellar Cataract
Lamellar or zonular cataract is a hereditary cataract that is transmitted in an autosomal dominant mode. The crystalline opacities are located at the level of the primary fibers in the embryonic nucleus. This cataract is...
A Rare Case of Benign Intracranial Hypertension with Bilateral Complete Visual Loss and Sixth Nerve Paresis
Introduction: Benign intracranial hypertension (BIH) is a disorder defined by symptoms and signs suggestive of increased intracranial pressure (ICP) in the absence of any cause evident on neuroimaging or other evaluation...
Intravitreal Bevacizumab Injection Effect in Exudative Age Related Macular Degeneration
Exudative age-related macular degeneration is the most common cause of vision loss of people over the age 60 in the developed countries. The cause is not clear yet, but since Avastin is largely used for the treatment, th...
Long-Term Outcome of Approved Pharmacotherapy for Diabetic Macular Edema: A Review of Randomized Controlled Trials in Fluocinolone Acetonide Implants, Dexamethasone Implants, Aflibercept and Ranibizumab
Diabetic macular edema (DME) is a major sight-threatening cause in diabetic patients. The pathophysiology of macular edema involves both the presence of inflammation and angiogenic stimulant regarding vascular endothelia...